Digital Therapeutics

We leverage data and insights collected via our digital biomarkers platform to deliver personalized, guideline-recommended therapies to manage, treat, and prevent diseases and disorders.

Product Pipeline

WELT-iis funded by the Korean Government (Ministry of Science and ICT)
WELT-EDis funded by the Korean Government (Ministry of Trade, Industry, and Energy)
WELT-Ais funded by Seoul Metropolitan Government
AGAINis funded by the Korean Government (Ministry of Trade, Industry, and Energy)


Restoring your sleep, powered by CBT-i and Digital Biomarkers.
Learn more

* WELT-i is a product candidate in development to treat chronic insomnia for adults 18 years and older.

Eating Disorders

Eating disorders have the highest mortality rate of any mental illness and in treating them many difficulties can arise and derail the treatment process. Patients with eating disorders are notoriously difficult to treat and are also known to have high relapse rates. In contrast to other mental disorders, in anorexia nervosa and bulimia nervosa years lived with disability (YLDs) have increased.

Work with Us


Alcohol use disorder is a pattern of alcohol use that involves problems controlling your drinking, being preoccupied with alcohol or continuing to use alcohol even when it causes problems. This disorder also involves having to drink more to get the same effect or having withdrawal symptoms when you rapidly decrease or stop drinking. Alcohol use disorder includes a level of drinking that's sometimes called alcoholism.

Work with Us